EXPANDING FUNDAMENTAL IMMUNOLOGICAL KNOWLEDGE AND TRANSLATING IT INTO DISCOVERIES THAT IMPROVE HUMAN AND ANIMAL HEALTH ON A GLOBAL SCALE

Established in 2015, the Center for Vaccines and Immunology (CVI) provides an environment for world-class research and training in immunology. The CVI is advancing fundamental and translational immunological knowledge to develop new vaccines and therapies for infectious diseases and other immunity-related diseases and syndromes.

 

Providing an environment for world-class immunology research


Latest News

Making Headlines: UGA Vet Med’s Year of Impact

In 2025, the University of Georgia College of Veterinary Medicine made headlines for excellence in teaching, research, and service. The college advanced impactful initiatives—from addressing the rural veterinarian shortage and combating avian influenza to pioneering traumatic brain injury treatments and advancing breakthrough Parkinson’s research. Join us as we celebrate a […]

More News

CVI Faculty Features

People, Parasites and Plagues Podcast

Episode 1: Dr. Mark Tompkins

Episode 35: Dr. Chet Joyner

This Week in Virology: Moo flu and dengue two

Awards

Fred C. Davison Early Career Scholar Award
Dr. Chet Joyner

Publications

Influenza hemagglutinin and neuraminidase multivalent vaccine elicits broader protective immune responses compared to vaccine formulations composed of hemagglutinin and neuraminidase
Hum Vaccin Immunother. December 2025

Elicitation of neutralizing antibodies and IgG4 subclass switching following booster vaccination with ancestral COVID-19 mRNA vaccines does not reduce breakthrough infections
Hum Vaccin Immunother. December 2025

Assessing factors associated with one-year antibody waning in participants with repeated influenza vaccinations: A six-year cohort study
Vaccine. December 2025

N-glycosylation at the receptor binding site drives differences in receptor binding specificity between influenza B virus lineages
J Virol. November 2025

Gene discovery and expression analysis of the B cell receptor repertoire in the domestic ferret model
Vaccine. October 2025

Active and Passive Immunization of Pan-Fungal Vaccine NXT-2 Reduces Morbidity and Mortality in an Immunosuppressed Murine Model of Candida auris Systemic Infection
Vaccines (Basel). October 2025

More publications


Related Projects & University Research Resources

Center for Influenza Disease & Emergence Research (CIDER)
Centers of Excellence for Influenza Research and Response (CEIRR)
Center for Tropical and Emerging Global Diseases (CTEGD)
Isakson Center for Neurological Disease Research (CNDR)
Precision One Health (POH)
Animal Health Research Center (AHRC)

going beyond the expected